In addition, in a patient with metastatic colon cancer, irbesartan inhibits activator protein 1 (AP-1) DNA binding and the JUN gene, resulting in a complete functional radiological resolution of the disease, showing its enormous potential in cancer treatment [78]. This evidence concerns the gene JUN and cancer.